Mepolizumab as a successful steroid-sparing agent in two patients with idiopathic hypereosinophilic syndrome (iHES)

Guo, CT; Bochner, BS

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018; 141 (2): AB278